Documented product family

Related FDA records

These links identify a sourced product-family relationship. They do not transfer evidence, metrics, clearance scope, compatibility, pricing, or availability between submissions.

MammoScreen reading aid

A partial mapping of MammoScreen 4 and 5 reading-aid records. Density products and other releases are not included in this mapping.

Therapixel identifies MammoScreen as its screening-mammography reading software. The manufacturer-prepared K260714 summary explicitly identifies K243679 as MammoScreen 4 and describes both as software versions of MammoScreen. This does not transfer tested input scenarios, evidence, licenses or availability between records.

Mapped FDA decisions, earliest first

Latest mapped does not mean latest sold or installed. Choose an exact FDA record before comparing.

  1. Related FDA recordMammoScreen® (4) (K243679)

    MammoScreen 4 reviewed in K243679

    FDA decision: 2025-07-03 · record reviewed 2026-11-05
  2. Related FDA recordMammoScreen® (5) (K260714)

    MammoScreen 5 reviewed in K260714

    Latest mapped FDA decisionFDA decision: 2026-06-26 · record reviewed 2026-11-05
Latest FDA decision among these records
K260714 · 2026-06-26. Latest decision among these mapped records only. This is not a current installed-version or supersession claim.
Latest documented release
The sources do not establish a complete current commercial release chronology.
Current commercial availability
Availability of an exact release and licensed configuration must be confirmed with the supplier.